A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia

Overview of attention for article published in Journal of Translational Medicine, June 2013

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)

Mentioned by

twitter: 1 tweeter
patent: 2 patents

facebook: 1 Facebook page

Citations

dimensions_citation: 153 Dimensions

Readers on

mendeley: 171 Mendeley

Summary Twitter Patents Facebook Dimensions citations

So far, Dimensions has found 153 publications that cite this research output.

153

The most recent citing publications are shown below. View all 153 publications that cite this research output on Dimensions.

Human bone marrow-derived, pooled, allogeneic mesenchymal stromal cells manufactured from multiple donors at different times show comparable biological functions in vitro, and in vivo to repair limb ischemia

Article in Stem Cell Research & Therapy (May 2021)

Minicircle‐based expression of vascular endothelial growth factor in mesenchymal stromal cells from diverse human tissues

Article in The Journal of Gene Medicine (April 2021)

Mesenchymal Stem Cell Transplantation for Ischemic Diseases: Mechanisms and Challenges

Article in Tissue Engineering and Regenerative Medicine (April 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.